在阿尔茨海默病中脑糖代谢的性别差异:基于voxel的研究
Matilde Nerattini1, Elisabetta Maria Abenavoli2, Francesca Caramelli3,4
1Department of Experimental and Clinical Biomedical Sciences, Nuclear Medicine Unit, University of Florence, Florence, Italy. matilde.nerattini@unifi.it.
GeroScience
|September 4, 2025
概括
阿尔茨海默病 (AD) 呈现出特定于性别的脑糖代谢差异. 妇女的前额低代谢率较高,而男性则表现出较高的表层衰退,影响了阿尔茨海默病的诊断和治疗.
科学领域:
- 神经成像和神经退化
- 阿尔茨海默病的病理生理学
- 年龄的性别差异
背景情况:
- 在阿尔茨海默病 (AD) 流行病学,临床表现和病理学方面存在显著的性别差异.
- 神经图像显示阿尔茨海默氏症的生物标志物未被充分研究,因此需要有针对性的研究.
- 了解这些变异对于发展阿尔茨海默病诊断和治疗至关重要.
研究的目的:
- 在AD痴呆症患者中使用FDG-PET研究大脑葡萄糖代谢的性别差异.
- 为了比较患有阿尔茨海默氏症的男性和女性的区域性低代谢模式.
- 探索特定性别神经成像发现对阿尔茨海默病理解的影响.
主要方法:
- 使用2-[18F]-2-脱氧-D-葡萄糖 (FDG) 进行静态脑静电断层扫描的分析.
- 包括247名患有AD痴呆症的老年人 (151名女性,96名男性).
- 基于Voxel的分析将FDG摄入量与规范数据库进行比较,并确定AD队列中的性别差异.
主要成果:
- 这两种性别都在AD易受伤害的区域表现出低代谢,例如角皮质,海马体和额叶.
- 与男性相比,女性在边缘和额头区域的低代谢率更高.
- 与女性相比,男性体内皮层的低代谢率更高.
结论:
- 在AD中观察到性别特异性的低代谢模式 (女性前部,男性后部).
- 这些发现表明神经生理和神经内分泌衰老对AD神经病理的贡献取决于性别.
- 识别这些差异可以完善阿尔茨海默病的诊断方法,并为特定性别的治疗策略提供信息.
更多相关视频
08:36Multi-Tracer Studies of Brain Oxygen and Glucose Metabolism Using a Time-of-Flight Positron Emission Tomography-Computed Tomography Scanner
Published on: June 7, 2024
391
07:28Studying Metabolic Brain Connectivity Using 2-Deoxy-2-[18F]Fluoro-D-Glucose Dynamic Positron Emission Tomography at the Single-subject Level
Published on: January 24, 2025
464
相关概念视频
Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666
Brain Imaging
308
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
308
